Half-life
11–12 minutes; stimulates prolonged GH pulse
Evidence Level
High Evidence
Mechanism of Action
Binds pituitary GHRH receptors to stimulate endogenous GH production. Preserves hypothalamic-pituitary feedback loop — prevents suppression of endogenous GH production.
Published Research Ranges & Study Context
Studies have administered: 0.2–0.3mg/kg at bedtime in clinical studies; 0.5–2mg/day studied
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
Extensive clinical trial history (FDA-reviewed). Studies demonstrate increased GH pulse amplitude and IGF-1 elevation with preservation of pulsatile physiology.
High Evidence
Multiple large human RCTs available
Side Effects Observed in Research
Generally well-tolerated; injection site redness, facial flushing in some studies
Available Configurations (SKU Reference)
SMO5
SMO10
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Sermorelin — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.